Fluor-built Bayer cell therapy facility in California achieves LEED v4 platinum certification
Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs
Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs
AstraZeneca and Daiichi Sankyo’s Enhertu followed by THP showed an improved safety profile vs. standard of care
Ticagrelor tablets are indicated for to reduce the risk of cardiovascular death and myocardial infarction,
Zydus MedTech gets rights to market the innovative Transcatheter Aortic Valve Implantation (TAVI) technology in India, Europe and other select markets
Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
Abbott's investigational Coronary Intravascular Lithotripsy (IVL) System offers a new potential treatment by using sound pressure waves to treat arterial calcium blockages
Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding Greater China region
PCC has secured the commercialization rights for the EU, UK, and Norway and will be responsible for distributing Neoatricon in these regions
Subscribe To Our Newsletter & Stay Updated